CLEC14A inhibitors
US9255148B2 · kind B2 · utility
1Cited by
12References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2010 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Jul 7, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inhibiting tumor angiogenesis in an individual, the method comprising administering to the individual an inhibitor of CLEC14A. The inhibitor may be an antibody, an siRNA molecule, an antisense molecule, or a ribozyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.